Tradestie Institutional Equity Comparison Engine
AVNS vs RBOT.WS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AVNS Overall Edge
AVNS Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avanos Medical, Inc. (AVNS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AVNS trades at 20.0x Forward P/E with 5.4% operating margin (+8.8% YoY revenue) versus RBOT.WS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AVNS sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AVNS
AVNS 20.0x vs RBOT.WS N/M Fwd P/E
Growth & Margin Winner
AVNS
Op Margin 5.4% vs N/A ยท YoY +8.8% vs N/A
Momentum & Technical Winner
AVNS
1Y +106.4% vs -67.2% ยท 52W Pos 97% vs 0%
Options & Structure Winner
AVNS
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (N/A IV)
AVNS
NYSE
Avanos Medical, Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$24.99
+0.04% 1D
Market Cap
$1.2B
1M Return
+0.16%
1Y Return
+106.36%
Forward P/E
20.0x
Unified AI Score
56.7 / 100
HOLD
Tech 75.0
Fund 59.0
Flow 50.0
Mom 46.9
RBOT.WS
NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap
N/A
1M Return
-67.2%
1Y Return
-67.2%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AVNS +106.36%
RBOT.WS -67.2%
Spread: +76.29 pp (AVNS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AVNS TTM Op. Margin: 5.4%
RBOT.WS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVNS vs RBOT.WS. Trailing 12-month operating profitability (AVNS 5.4% vs RBOT.WS N/A) and valuation multiples (AVNS 20.0x vs RBOT.WS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AVNS | RBOT.WS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | N/A | Larger Scale | AVNS |
| Trailing P/E Ratio Valuation | 30.7x | N/M | Lower Multiple | AVNS |
| Forward P/E Ratio Valuation | 20.0x | N/M | Lower Multiple | AVNS |
| Revenue Growth (YoY) Growth | +8.8% | N/A | Higher Growth | AVNS |
| Operating Margin (TTM) Profitability | 5.4% | N/A | Higher Margin | AVNS |
| Net Profit Margin Profitability | -10.4% | N/A | Higher Margin | AVNS |
| Return on Equity (ROE) Capital Efficiency | -9.2% | N/A | Higher ROE | AVNS |
| 52-Week Range Position Momentum | 97% ($9โ$25) | 0% ($0โ$0) | Stronger Trend | AVNS |
| Beta / 30D Volatility Risk Regime | 1.22ฮฒ ยท 6% Vol | N/A | Lower Realized Risk | AVNS |
| Unified Institutional Score Composite Signal | 56.7 / 100 (HOLD) | 50.1 / 100 (HOLD) | Higher Composite | AVNS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AVNS vs RBOT.WS Buy Guide
AVNS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
RBOT.WS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AVNS nor RBOT.WS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.